These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Silymarin, a membranotropic drug: clinical and experimental observations]. De Martiis M; Fontana M; Sebastiani F; Parenzi A Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785 [No Abstract] [Full Text] [Related]
6. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice]. André W Munch Med Wochenschr; 1966 Mar; 108(11):610-1. PubMed ID: 6013869 [No Abstract] [Full Text] [Related]
7. [Metabolism pathways and use of heptral in chronic liver diseases]. Il'chenko LIu; Vinnitskaia EV Eksp Klin Gastroenterol; 2002; (2):62-4, 103. PubMed ID: 12046390 [TBL] [Abstract][Full Text] [Related]
8. [Clinical and experimental study of shuangcao tuihuang granule-1 in treating severe jaundice of acute icterohepatitis]. Lian YX; Long XY; Wu WF Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Sep; 21(9):649-51. PubMed ID: 12575547 [TBL] [Abstract][Full Text] [Related]
9. Treatment of liver disease with corticosteroids. Lesesne HR; Fallon HJ Med Clin North Am; 1973 Sep; 57(5):1191-201. PubMed ID: 4593197 [No Abstract] [Full Text] [Related]
10. [Silymarin action in liver diseases]. Hammerl H; Pichler O; Studlar M Med Klin; 1971 Sep; 66(36):1204-8. PubMed ID: 5096207 [No Abstract] [Full Text] [Related]
11. Medical evaluation of the patient with liver disease prior to surgery. Blundell CR; Earnest DL Contemp Anesth Pract; 1981; 4():123-69. PubMed ID: 7014090 [TBL] [Abstract][Full Text] [Related]
12. Malotilate: the new hope for a clinically effective agent for the treatment of liver disease. Ryle PR; Dumont JM Alcohol Alcohol; 1987; 22(2):121-41. PubMed ID: 3307796 [No Abstract] [Full Text] [Related]
13. Role of extracellular vesicles in liver diseases and their therapeutic potential. Kostallari E; Valainathan S; Biquard L; Shah VH; Rautou PE Adv Drug Deliv Rev; 2021 Aug; 175():113816. PubMed ID: 34087329 [TBL] [Abstract][Full Text] [Related]
14. [Reflections on prednisone therapy of patients with liver diseases]. Teichmann W Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421 [No Abstract] [Full Text] [Related]
15. Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense? Bannert K; Kuhla A; Abshagen K; Vollmar B Apoptosis; 2014 Aug; 19(8):1243-53. PubMed ID: 24872082 [TBL] [Abstract][Full Text] [Related]